Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-89.76	313.53	3060.40
Graham Fair Price	147.41	3.10	1.25
PEG	-97.73	0.13	-5.55
Price/Book	-24.47	3.72	4.92
Price/Cash Flow	321.90	-79.29	18.79
Prices/Earnings	-86.85	62.06	471.89
Price/Sales	-11.48	28.50	32.20
Price/FCF	321.90	-79.29	18.79
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.54	0.36	0.49
Operating Margin	48.28	0.11	0.08
ROA	505.52	0.01	< 0.005
ROE	< 0.005	0.01	474.26
ROIC	0.01	0.01	-11.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.29	0.52	-44.25
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.52	0.28	-44.86
EPS QOQ	-0.85	4.93	479.52
FCF QOQ	6.71	-1.18	-82.40
Revenue QOQ	0.14	-0.13	-1.03
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	283.71	222.74	-21.49
Days Sales Outstanding (DSO)	79.31	99.64	25.64
Inventory Turnover	0.32	0.40	27.38
Debt/Capitalization	0.14	0.10	-27.07
Quick Ratio	1.03	0.93	-10.35
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.18	5.35	3.24
Cash	1.47	0.86	-41.18
Capex	-0.03	< 0.005	86.13
Free Cash Flow	1.36	-0.25	-81.52
Revenue	0.79	0.70	-11.92
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.78	3.21	15.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-80.27	-4.20	94.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating